FDA has updated its drug shortage list. The status of both molecules has implications for 503A and 503B compounding enforcement discretion.
FDA shortage list updated; compounding pathway implications.
FDA has updated its drug shortage list. The status of both molecules has implications for 503A and 503B compounding enforcement discretion.
Five minutes. Free. No pressure.